Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neurology

• Publication date

  2012-09-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e31826aac4ePMID 22914827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.

  2011cited by this paper
• Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

  2011cited by this paper
• Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients

  2011cited by this paper
• Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis

  2011cited by this paper
• Faculty Opinions recommendation of Neuromyelitis optica in France: a multicenter study of 125 patients.

  2010cited by this paper
• Neuromyelitis optica in France

  2010cited by this paper
• Neuromyelitis optica in Brazil: a study on clinical and prognostic factors

  2009cited by this paper
• Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

  2009cited by this paper
• Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis1

  2009cited by this paper
• Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

  2008cited by this paper
• IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†

  2008cited by this paper
• Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein

  2007cited by this paper
• Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

  2006cited by this paper
• IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

  2005cited by this paper
• The Journal of Experimental Medicine CORRESPONDENCE

  2005cited by this paper
• Acute disseminated encephalomyelitis: A follow-up study of 40 adult patients

  2001cited by this paper
• The clinical course of neuromyelitis optica (Devic’s syndrome)

  1999cited by this paper
• The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.

  1995cited by this paper

• Dual AQP4-IgG and MOG-IgG Seropositivity in a 75-Year-Old Woman: Challenging the Mutual Exclusivity Paradigm in NMOSD

  2026cites this paper
• From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions.

  2026cites this paper
• Progress on experimental models of neuromyelitis optica spectrum disease

  2025cites this paper
• Decoding paraneoplastic neuromyelitis optica: a multi-omics investigation of tumor-driven T and B cell dynamics

  2025cites this paper
• Translational insights from EAE models : decoding MOGAD pathogenesis and therapeutic innovation

  2025cites this paper
• Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Insights into pathogenesis and biomarkers of prognosis.

  2025cites this paper
• Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Mechanisms, Syndromes, and Management.

  2025cites this paper
• Consensus recommendations for the diagnosis and management of neuromyelitis optica spectrum disorder: A Saudi expert panel review.

  2025cites this paper
• Therapeutic plasma exchange for MOG antibody-associated disease attacks: a systematic review and meta-analysis.

  2025cites this paper
• Prevalence of anti-myelin oligodendrocyte glycoprotein antibodies across neuroinflammatory and neurodegenerative diseases.

  2024cites this paper
• Cell-Based Assay to Detect the Autoantibody Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD).

  2024cites this paper
• Antibodies to neural cell surface and synaptic proteins in paraneoplastic neurologic syndromes.

  2024cites this paper
• Retinal Changes in Double-Antibody Seronegative Neuromyelitis Optica Spectrum Disorders

  2024cites this paper
• Autoantibody-mediated central nervous system channelopathies.

  2024cites this paper
• MOG antibody-associated optic neuritis

  2024cites this paper
• MOG-IgG is rare in AQP4-IgG seronegative NMO phenotype in Brazil.

  2024cites this paper
• Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series

  2024cites this paper
• Antibodies in neurological diseases: Established, emerging, explorative

  2024cites this paper
• Clinical characteristics of double negative atypical inflammatory demyelinating disease: A prospective study

  2024cites this paper
• Visual evoked potential in myelin oligodendrocyte glycoprotein antibody-associated disease

  2024cites this paper
• Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022

  2024cites this paper
• Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice.

  2024cites this paper
• A protective effect of lower MHC-II expression in MOGAD.

  2024cites this paper
• Decipher potential biomarkers of diagnosis and disease activity for NMOSD with AQP4 using LC-MS/MS and Simoa.

  2023cites this paper
• Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

  2023cites this paper
• Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease.

  2023cites this paper
• MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity

  2023cites this paper
• AQUAPORIN-4 (AQP-4) IMMUNOGLOBULIN G SEROPOSITIVE NEUROMYELITIS OPTICA: A REVIEW AND CASE REPORT

  2023cites this paper
• MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis

  2023cites this paper
• High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting

  2023cites this paper
• Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders

  2023cites this paper
• Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide

  2023cites this paper
• Clinical characteristic of myelin oligodendrocyte glycoprotein antibody associated cortical encephalitis in adults and outcomes following glucocorticoid therapy

  2023cites this paper
• [A case of anti-myelin oligodendrocyte glycoprotein antibody-positive multiphasic disseminated encephalomyelitis showing significant recovery after immunoadsorption plasmapheresis].

  2023cites this paper
• Efficacy of monoclonal antibodies in neuromyelitis optica: An updated systematic review with meta‐analysis

  2022influential citation
• Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course

  2022cites this paper
• Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease

  2022cites this paper
• Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

  2022cites this paper
• Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders

  2022cites this paper
• Myelin Oligodendrocyte Glycoprotein–Associated Disorders

  2022cites this paper
• Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore

  2022cites this paper
• Epidemiología del espectro de neuromielitis óptica. Nuevos y viejos desafíos

  2022cites this paper
• The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use

  2022cites this paper
• The Postpartum Period Can Worsen Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalomyelitis

  2022cites this paper
• Diagnostik der Neuromyelitis-optica-Spektrum-Erkrankung (NMOSD) und der MOG-Antikörper-assoziierten Erkrankung (MOGAD)

  2022cites this paper
• Serologie, Diagnose

  2022cites this paper
• The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience

  2022cites this paper
• Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders

  2022cites this paper
• Meningo-cortical manifestations of myelin oligodendrocyte glycoprotein antibody-associated disease: Review of a novel clinico-radiographic spectrum

  2022cites this paper
• Maturation of circulating Ly6ChiCCR2+ monocytes by mannan-MOG induces antigen-specific tolerance and reverses autoimmune encephalomyelitis

  2022cites this paper
• Incidence and Prevalence of Neuromyelitis Optica Spectrum Disorders in the Background of International Consensus Diagnostic Criteria - A Systematic Review.

  2022cites this paper
• The Prevalence, Demographics, Clinical Features, Neuroimaging, and Inter-ethnic Differences of MOGAD in Malaysia with Global Perspectives.

  2022cites this paper
• Serologie, Diagnose

  2022cites this paper
• Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review

  2022influential citation
• Immunobiology of neuromyelitis optica spectrum disorders.

  2022cites this paper
• Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives

  2022cites this paper
• Simultaneous screening for antibodies to myelin oligodendrocyte glycoprotein and aquaporin-4 in patients with optic neuritis using cell-based assay

  2022cites this paper
• Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy

  2022cites this paper
• New Treatment Perspectives for Acute Relapses in Neuromyelitis Optica Spectrum Disorder.

  2022cites this paper
• Clinical and Radiological Features of Myelin Oligodendrocyte Glycoprotein-Associated Myelitis in Adults

  2022cites this paper
• Myélopathies inflammatoires : de la SEP à la NMO

  2022cites this paper
• Case Report: Four Cases of Cortical/Brainstem Encephalitis Positive for Myelin Oligodendrocyte Glycoprotein Immunoglobulin G

  2022cites this paper
• Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination

  2022cites this paper
• Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review

  2021cites this paper
• The changing landscape of optic neuritis: a narrative review

  2021cites this paper
• Randomized Controlled Trials for Neuromyelitis Optica Spectrum Disorder

  2021cites this paper
• Lymphocyte Subsets Are Associated with Disease Status in Neuromyelitis Optica Spectrum Disorders

  2021cites this paper
• Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis

  2021cites this paper
• Neuromyelitis-optica-Spektrum-Erkrankungen – alte und neue Entwicklungen

  2021cites this paper
• Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI

  2021cites this paper
• Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro‐ophthalmic review

  2021cites this paper
• Uncommon inflammatory/immune-related myelopathies.

  2021cites this paper
• An uncommon cause of vertigo: Neuromyelitis optica spectrum disorder

  2021cites this paper
• [Neuromyelitis Optica Spectrum Disorders - Present Insights and Recent Developments].

  2021cites this paper
• Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.

  2021cites this paper
• Systematic Review and Meta-analysis of Eculizumab, Inebilizumab, Tocilizumab, and Satralizumab for Neuromyelitis Optica

  2021cites this paper
• Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease

  2021cites this paper
• Anti‐myelin oligodendrocyte glycoprotein antibody‐associated disease presenting tumefactive demyelinating lesions and bilateral optic neuritis with chiasmatic lesion

  2021cites this paper
• Safety and E cacy of IL-6 Inhibitors in the Treatment of Neuromyelitis Optica Spectrum Disorders. A Meta-analysis

  2021cites this paper
• Clinical Approach to Pediatric Demyelinating Disease

  2021cites this paper
• Central nervous system inflammatory demyelinating diseases and neuroimmunology in Singapore—Epidemiology and evolution of an emerging subspecialty

  2021cites this paper
• Elucidating distinct clinico-radiologic signatures in the borderland between neuromyelitis optica and multiple sclerosis

  2021cites this paper
• PLEX: the best first-line treatment in nmosd attacks experience at a single center in Colombia

  2021cites this paper
• Clinical Approach to Autoimmune and Inflammatory Ophthalmologic Disease

  2021cites this paper
• The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis.

  2021cites this paper
• External cervical resorption detected via cone‐beam computed tomography in a patient with myelin oligodendrocyte glycoprotein antibody–associated disease: A case report

  2021cites this paper
• MOG-IgG Associated Disease (MOG-AD) in Adults

  2021cites this paper
• Research Paper: Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder

  2021cites this paper
• Spinal Cord Compression and Myelopathies

  2021cites this paper
• Myelitis and Other Autoimmune Myelopathies

  2021cites this paper
• Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel

  2021cites this paper
• AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.

  2021cites this paper
• Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil.

  2021cites this paper
• What percentage of AQP4-ab-negative NMOSD patients are MOG-ab positive? A study from the Argentinean multiple sclerosis registry (RelevarEM).

  2021cites this paper
• Entzündliche Erkrankungen des zentralen Nervensystems

  2021cites this paper
• Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders.

  2020cites this paper
• Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?

  2020cites this paper
• Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies

  2020cites this paper
• Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease

  2020cites this paper
• Different Targets of Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders: A Meta-Analysis Evidenced From Randomized Controlled Trials

  2020cites this paper